49 related articles for article (PubMed ID: 11500059)
1. Regulation of c-Myb activity by tumor suppressor p53.
Tanikawa J; Ichikawa-Iwata E; Kanei-Ishii C; Ishii S
Blood Cells Mol Dis; 2001; 27(2):479-82. PubMed ID: 11500059
[TBL] [Abstract][Full Text] [Related]
2. p53 suppresses the c-Myb-induced activation of heat shock transcription factor 3.
Tanikawa J; Ichikawa-Iwata E; Kanei-Ishii C; Nakai A; Matsuzawa S; Reed JC; Ishii S
J Biol Chem; 2000 May; 275(20):15578-85. PubMed ID: 10747903
[TBL] [Abstract][Full Text] [Related]
3. Expression of stress response protein glucose regulated protein-78 mediated by c-Myb.
Ramsay RG; Ciznadija D; Mantamadiotis T; Anderson R; Pearson R
Int J Biochem Cell Biol; 2005 Jun; 37(6):1254-68. PubMed ID: 15778089
[TBL] [Abstract][Full Text] [Related]
4. Three genes with different functions in transformation are regulated by c-Myb in myeloid cells.
Wolff L; Schmidt M; Koller R; Haviernik P; Watson R; Bies J; Maciag K
Blood Cells Mol Dis; 2001; 27(2):483-8. PubMed ID: 11259171
[TBL] [Abstract][Full Text] [Related]
5. Activation of heat shock transcription factor 3 by c-Myb in the absence of cellular stress.
Kanei-Ishii C; Tanikawa J; Nakai A; Morimoto RI; Ishii S
Science; 1997 Jul; 277(5323):246-8. PubMed ID: 9211854
[TBL] [Abstract][Full Text] [Related]
6. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
[TBL] [Abstract][Full Text] [Related]
7. Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis.
Koutsodontis G; Vasilaki E; Chou WC; Papakosta P; Kardassis D
Biochem J; 2005 Jul; 389(Pt 2):443-55. PubMed ID: 15790310
[TBL] [Abstract][Full Text] [Related]
8. p53-mediated activation of miRNA34 candidate tumor-suppressor genes.
Bommer GT; Gerin I; Feng Y; Kaczorowski AJ; Kuick R; Love RE; Zhai Y; Giordano TJ; Qin ZS; Moore BB; MacDougald OA; Cho KR; Fearon ER
Curr Biol; 2007 Aug; 17(15):1298-307. PubMed ID: 17656095
[TBL] [Abstract][Full Text] [Related]
9. Targeted disruption of c-myb in the chicken pre B-cell line DT40.
Appl H; Klempnauer KH
Oncogene; 2002 May; 21(19):3076-81. PubMed ID: 12082539
[TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
[TBL] [Abstract][Full Text] [Related]
11. c-Myb associates with PML in nuclear bodies in hematopoietic cells.
Dahle Ø; Bakke O; Gabrielsen OS
Exp Cell Res; 2004 Jul; 297(1):118-26. PubMed ID: 15194430
[TBL] [Abstract][Full Text] [Related]
12. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
[TBL] [Abstract][Full Text] [Related]
14. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F.
Hershko T; Chaussepied M; Oren M; Ginsberg D
Cell Death Differ; 2005 Apr; 12(4):377-83. PubMed ID: 15706352
[TBL] [Abstract][Full Text] [Related]
15. Heat shock factors at a crossroad between stress and development.
Akerfelt M; Trouillet D; Mezger V; Sistonen L
Ann N Y Acad Sci; 2007 Oct; 1113():15-27. PubMed ID: 17483205
[TBL] [Abstract][Full Text] [Related]
16. Disruption of B-myb in DT40 cells reveals novel function for B-Myb in the response to DNA-damage.
Ahlbory D; Appl H; Lang D; Klempnauer KH
Oncogene; 2005 Nov; 24(48):7127-34. PubMed ID: 16170378
[TBL] [Abstract][Full Text] [Related]
17. c-myb stimulates cell growth by regulation of insulin-like growth factor (IGF) and IGF-binding protein-3 in K562 leukemia cells.
Kim MS; Kim SY; Arunachalam S; Hwang PH; Yi HK; Nam SY; Lee DY
Biochem Biophys Res Commun; 2009 Jul; 385(1):38-43. PubMed ID: 19427836
[TBL] [Abstract][Full Text] [Related]
18. A positive feedback mechanism in the transcriptional activation of Apaf-1 by p53 and the coactivator Zac-1.
Rozenfeld-Granot G; Krishnamurthy J; Kannan K; Toren A; Amariglio N; Givol D; Rechavi G
Oncogene; 2002 Feb; 21(10):1469-76. PubMed ID: 11896574
[TBL] [Abstract][Full Text] [Related]
19. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network.
Menendez D; Krysiak O; Inga A; Krysiak B; Resnick MA; Schönfelder G
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1406-11. PubMed ID: 16432214
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated expression of dominant negative c-myb induces apoptosis in head and neck cancer cells and inhibits tumor growth in animal model.
Kim SY; Yang YS; Hong KH; Jang KY; Chung MJ; Lee DY; Lee JC; Yi HK; Nam SY; Hwang PH
Oral Oncol; 2008 Apr; 44(4):383-92. PubMed ID: 17690006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
